Literature DB >> 22336877

Is auditory function affected after Le Fort I osteotomy?

B Bayram1, K Deniz, E Aydin, S Uckan.   

Abstract

The aim of this study was to evaluate changes to the Eustachian tube and middle ear function and hearing level in individuals undergoing Le Fort I osteotomy. 20 consecutive patients underwent Le Fort I maxillary osteotomy with advancement, impaction or a combination of both. All individuals underwent hearing sensitivity tests, including pure tone audiometry and acoustic impedance measurements (middle ear pressure and compliance), which were carried out by an audiologist 1 week before surgery (t(0)), and then again 1 week (t(1)) and 4 weeks (t(2)) after surgery. Regarding pure tone audiometry, the differences between t(0) and t(2) at a frequency of 125Hz (P=.002), between t(0) and t(1) and between t(0) and t(2) at a frequency of 250Hz, and between t(0) and t(1) at a frequency of 1000Hz (P=.006) were statistically significant. There was no statistically significant difference at any other frequency. Regarding middle ear pressure, no statistically significant difference was observed between t(0) and t(1), and t(0) and t(2). Following Le Fort I osteotomy, mild changes in hearing sensitivity and middle ear pressure are possible, but these changes were clinically insignificant.
Copyright © 2012 International Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22336877     DOI: 10.1016/j.ijom.2012.01.011

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Surg        ISSN: 0901-5027            Impact factor:   2.789


  2 in total

1.  The effects of orthognathic surgery on auditory function.

Authors:  Farhad Ghorbani; Hossein Danesteh; Afshin Khoramnia; Saeid Tavanafar
Journal:  Maxillofac Plast Reconstr Surg       Date:  2021-03-25

Review 2.  Complications associated with orthognathic surgery.

Authors:  Young-Kyun Kim
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2017-02-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.